Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Research Report 2024

Publication ID:

PB501246574

Publication Date:

January 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital鈩� PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
The global Real-time PCR (qPCR) and Digital PCR (dPCR) market was valued at US$ 1315 million in 2023 and is anticipated to reach US$ 1967.4 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.
This report aims to provide a comprehensive presentation of the global market for Real-time PCR (qPCR) and Digital PCR (dPCR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-time PCR (qPCR) and Digital PCR (dPCR).
Report Scope
The Real-time PCR (qPCR) and Digital PCR (dPCR) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Real-time PCR (qPCR) and Digital PCR (dPCR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Real-time PCR (qPCR) and Digital PCR (dPCR) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher
Bio-rad
Segment by Type
Digital Microfluidic Chip PCR
Droplet Digital PCR
Segment by Application
Medical Institutions
Universities and Research Institutes
Government
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Real-time PCR (qPCR) and Digital PCR (dPCR) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Digital Microfluidic Chip PCR
1.2.3 Droplet Digital PCR
1.3 麻豆原创 by Application
1.3.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Institutions
1.3.3 Universities and Research Institutes
1.3.4 Government
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Perspective (2019-2030)
2.2 Real-time PCR (qPCR) and Digital PCR (dPCR) Growth Trends by Region
2.2.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Real-time PCR (qPCR) and Digital PCR (dPCR) Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Real-time PCR (qPCR) and Digital PCR (dPCR) Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Dynamics
2.3.1 Real-time PCR (qPCR) and Digital PCR (dPCR) Industry Trends
2.3.2 Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Drivers
2.3.3 Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Challenges
2.3.4 Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-time PCR (qPCR) and Digital PCR (dPCR) Players by Revenue
3.1.1 Global Top Real-time PCR (qPCR) and Digital PCR (dPCR) Players by Revenue (2019-2024)
3.1.2 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue
3.4 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Concentration Ratio
3.4.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue in 2023
3.5 Real-time PCR (qPCR) and Digital PCR (dPCR) Key Players Head office and Area Served
3.6 Key Players Real-time PCR (qPCR) and Digital PCR (dPCR) Product Solution and Service
3.7 Date of Enter into Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-time PCR (qPCR) and Digital PCR (dPCR) Breakdown Data by Type
4.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Forecasted 麻豆原创 Size by Type (2025-2030)
5 Real-time PCR (qPCR) and Digital PCR (dPCR) Breakdown Data by Application
5.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size (2019-2030)
6.2 North America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2019-2024)
6.4 North America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size (2019-2030)
7.2 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2019-2024)
7.4 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size (2019-2030)
9.2 Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Real-time PCR (qPCR) and Digital PCR (dPCR) 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Real-time PCR (qPCR) and Digital PCR (dPCR) Introduction
11.1.4 Thermo Fisher Revenue in Real-time PCR (qPCR) and Digital PCR (dPCR) Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Bio-rad
11.2.1 Bio-rad Company Detail
11.2.2 Bio-rad Business Overview
11.2.3 Bio-rad Real-time PCR (qPCR) and Digital PCR (dPCR) Introduction
11.2.4 Bio-rad Revenue in Real-time PCR (qPCR) and Digital PCR (dPCR) Business (2019-2024)
11.2.5 Bio-rad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher
Bio-rad

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.